Stay updated on Sustained Release Dalfampridine in Transverse Myelitis Clinical Trial
Sign up to get notified when there's something new on the Sustained Release Dalfampridine in Transverse Myelitis Clinical Trial page.

Latest updates to the Sustained Release Dalfampridine in Transverse Myelitis Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedFooter now shows Revision: v3.6.5, replacing v3.6.4. This is a minor software version update and does not change study content or page functionality.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedRevision marker updated to v3.6.4 on the page footer, indicating a new deployment. The study content and data remain unchanged.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page footer shows Revision: v3.6.3, replacing v3.6.2, indicating a small maintenance update to the site.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2, indicating a platform/template update that affects the page wrapper rather than study information.SummaryDifference0.1%

- Check73 days agoChange DetectedThe study page now indicates that it is no longer recruiting participants, signaling that enrollment is closed. New navigation and guidance sections such as How to Read a Study Record, Common Questions, How to Join a Study, and an Intervention/Treatment heading were added, reflecting a reorganization and improved user guidance.SummaryDifference0.5%

- Check80 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5, reflecting a small update to the page's content.SummaryDifference0.1%

Stay in the know with updates to Sustained Release Dalfampridine in Transverse Myelitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sustained Release Dalfampridine in Transverse Myelitis Clinical Trial page.